Package 0002-7678-01

{"route": ["INTRAVENOUS"], "spl_id": "8f4af9a3-1e45-4174-a2a7-31477f46901a", "openfda": {"nui": ["N0000191009", "N0000020032"], "unii": ["D99YVK4L0X"], "rxcui": ["1657775", "1657777", "1657780", "1657781"], "spl_set_id": ["c6080942-dee6-423e-b688-1272c2ae90d4"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]"], "pharm_class_moa": ["VEGFR2 Inhibitors [MoA]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0002-7678-01)  / 50 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "0002-7678-01", "marketing_start_date": "20140421"}], "brand_name": "CYRAMZA", "product_id": "0002-7678_8f4af9a3-1e45-4174-a2a7-31477f46901a", "dosage_form": "SOLUTION", "pharm_class": ["VEGFR2 Inhibitors [MoA]", "Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]"], "product_ndc": "0002-7678", "generic_name": "ramucirumab", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CYRAMZA", "active_ingredients": [{"name": "RAMUCIRUMAB", "strength": "10 mg/mL"}], "application_number": "BLA125477", "marketing_category": "BLA", "marketing_start_date": "20140421", "listing_expiration_date": "20261231"}